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Abstract
Background: DNA methylation has been recognized as a key mechanism in cell differentiation. Various studies
have compared tissues to characterize epigenetically regulated genomic regions, but due to differences in study
design and focus there still is no consensus as to the annotation of genomic regions predominantly involved in
tissue-specific methylation. We used a new algorithm to identify and annotate tissue-specific differentially
methylated regions (tDMRs) from Illumina 450k chip data for four peripheral tissues (blood, saliva, buccal swabs and
hair follicles) and six internal tissues (liver, muscle, pancreas, subcutaneous fat, omentum and spleen with matched
blood samples).
Results: The majority of tDMRs, in both relative and absolute terms, occurred in CpG-poor regions. Further analysis
revealed that these regions were associated with alternative transcription events (alternative first exons, mutually
exclusive exons and cassette exons). Only a minority of tDMRs mapped to gene-body CpG islands (13%) or CpG
islands shores (25%) suggesting a less prominent role for these regions than indicated previously. Implementation
of ENCODE annotations showed enrichment of tDMRs in DNase hypersensitive sites and transcription factor
binding sites. Despite the predominance of tissue differences, inter-individual differences in DNA methylation in
internal tissues were correlated with those for blood for a subset of CpG sites in a locus- and tissue-specific manner.
Conclusions: We conclude that tDMRs preferentially occur in CpG-poor regions and are associated with alternative
transcription. Furthermore, our data suggest the utility of creating an atlas cataloguing variably methylated regions
in internal tissues that correlate to DNA methylation measured in easy accessible peripheral tissues.
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Background
Epigenetic mechanisms, including DNA methylation, are
essential in mammalian development and cell differenti-
ation [1]. Several studies have compared genome-wide
DNA methylation patterns, particularly of cytosine at
CpG dinucleotides, between human cell types and tis-
sues to identify general characteristics of genomic re-
gions that define epigenetic differences between tissues
[2-4]. However, these studies often focused on a subset
of regions either because of a priori hypotheses or due
to the limited coverage of the DNA methylation profil-
ing technology used. For example, while many studies
have explored and identified tissue-specific differentially
methylated regions (tDMRs) at promoter sequences
[2,4-8], differential methylation at other genomic regions
has been investigated less widely and consistently. Sev-
eral studies focussed on CpG islands (CGIs), which are
genomic regions with a high density of CpGs, and
reported the predominant occurrence of tDMR CGIs lo-
cated in the gene bodies [9-11] and described their po-
tential role in regulating alternative transcription start
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sites [10]. One study highlighted the 2 kb region flanking
CGIs (that is, CGI shores) as a frequent target of tissue-
specific methylation [12], but this finding was not repli-
cated in a mouse study [9].
To study the contribution of epigenetic variation to
human disease risk, it is necessary not only to study tis-
sue differences, but also to explore the correlation of
DNA methylation signatures between tissues. Many dis-
eases involve internal organs (IOs) that cannot be sam-
pled in human subjects participating in epidemiological
studies. Studies of such diseases would be facilitated if
methylation of DNA from peripheral tissues could be
used as a proxy; that is, if inter-individual variation in
DNA methylation levels at a genomic region that is ob-
served in a population is positively correlated with that
in an (unmeasured) internal organ. Although candidate
region [13] and genome-wide [11] studies suggested that
correlated DNA methylation across tissues may occur,
little is known about the prevalence of such correlations.
In this study, we explored genome-wide DNA methy-
lation in six internal and four peripheral tissues in two
independent datasets using the Illumina 450k methyla-
tion chip [14,15]. Apart from systematically covering
promoter regions, CGIs and CGI shores, the chip targets
sufficient CpG dinucleotides outside these regions to
study other annotations. We implemented an algorithm
to identify tDMRs, which allowed us to detect statisti-
cally robust and biologically relevant tDMRs in 450k
data. This allowed us to evaluate previously indicated
annotations of tDMRs systematically in a single study. In
addition, we explored annotations utilizing more recent
insights on genome biology including those from the
ENCODE project. Finally, we evaluated the occurrence
of correlated DNA methylation across tissues.
Results
Identification of tDMRs
Genome-wide DNA methylation data was generated
from four peripheral tissues (blood, saliva, hair follicles
and buccal swabs) from five individuals, and six internal
tissues (subcutaneous fat, omentum, muscle, liver, spleen
and pancreas) and blood from six individuals, using
Illumina 450k DNA methylation chips (Additional file 1:
Table S1). The DNA methylation patterns observed in the
tissues were in concordance with previously described
characteristics: the distribution of DNA methylation was
bimodal with a minority of CG dinucleotides showing
intermediate DNA methylation levels (Additional file 2:
Figure S1A, B); the canonical pattern of low DNA methy-
lation around transcription start sites (TSSs) was observed
(Additional file 3: Figure S2A); and, finally, adjacent
CpGs within 1 kb had similar DNA methylation levels
(Additional file 3: Figure S2B).
Tissue types tended to cluster together according
to genome-wide DNA methylation data indicating
the occurrence of tissue-specific methylation patterns
(Additional file 2: Figure S1E, F). To study these patterns
in more detail, we developed an algorithm to identify
tissue-specific differentially methylated regions sys-
tematically using 450k methylation data as described
in Figure 1 (also see Methods). Briefly, first tissue-specific
differentially methylated positions (tDMPs) were identified.
tDMPs were defined as CpGs with a DNA methylation
difference between tissues that was: (1) genome-wide
significant (P < 10-7) and (2) had a mean sum of
squares ≥ 0.01 (equals (10%)2, that is, the mean of the
difference between the individual tissues and the over-
all mean across tissues should be greater than 10%).
Next, differentially methylated regions (DMRs) were
identified as regions with at least three differentially
methylated positions (DMPs) with an inter-CpG dis-
tance ≤ 1 kb, interrupted by at most three non-DMPs
across the whole DMR (see Methods; the algorithm is
in Additional file 4). The algorithm detected 3,533 and
5,382 tDMRs in the peripheral and internal tissue datasets,
respectively (Table 1 and Additional file 5: Table S2).
There were 4,877 unique (that is, non-overlapping)
tDMRs between datasets. Interestingly, 2,019 tDMRs
were detected in both peripheral and internal tissues
(9,388 CpGs in common, P < 0.001). The tDMR distribu-
tion over the genome was similar for the two datasets
(Additional file 3: Figure S2C). A further indication of the
validity of the tDMRs was obtained from a visualization
of the tDMRs in a heat map according to tissue, which
showed the expected clustering by germ layer and con-
firmed the previously reported cellular similarities be-
tween blood and saliva, and between hair and buccal
swabs (Additional file 6: Figure S3) [16].
tDMRs accumulate near genes expressed in specific
tissues
tDMRs were mapped to their nearest gene and the
TiGER database was used to verify the expectation that
these genes are preferentially expressed in investigated
tissues [17]. This was indeed the case (Additional file 7:
Figure S4A, Additional file 5: Table S2). For example,
tDMRs in the internal tissue dataset mapped preferen-
tially to liver-specific genes (odds ratio for internal or-
gans ORI = 5.01, P < 10
-5). In contrast, this was not
observed in the peripheral tissue dataset (odds ratio for
peripheral tissues ORP = 1.02, P = 0.13). Enrichment of
the blood-specific expression of genes adjacent to identi-
fied tDMRs was observed in both datasets (ORP = 2.42,
P < 10-5; ORI = 1.88, P < 10
-5). Furthermore, tDMRs
mapping to genes with tissue-specific expression were
hypomethylated in the tissue in which the gene is prefer-
entially expressed compared with other tissues. This is
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in line with an inverse relationship between DNA methy-
lation and expression (Additional file 7: Figure S4B).
Taken together, these analyses indicate that our algorithm
detected a tDMR set that is not only statistically robust
but also biologically relevant.
tDMRs associate with specific genomic annotations
In order to systematically assess previous observations
regarding tDMR annotations and to further explore
annotations that became available more recently, we
created extensive annotations of CpG sites interro-
gated with the 450k chip (the annotations can be found
in Additional file 8) and evaluated their enrichment in
tDMRs. First, tDMR CpGs were annotated according
to the location relative to genes. This showed that the
occurrence of tDMRs in proximal promoters (defined
as −1500 to +500 from a TSS) was depleted, whereas it
was enriched in other gene-centric annotations (Additional
file 9: Figure S5). This pattern was highly concordant be-
tween internal and peripheral tissues (for example, for
proximal promoters ORP = 0.70 and ORI = 0.68, P < 10
-5).
Next, we combined the gene-centric annotation with a
CGI-centric annotation (Figure 2). The combined an-
notation revealed that the overall depletion in proximal
promoters was due to a strong underrepresentation of
tDMRs in CGI proximal promoters (Figure 2, ORP = 0.15,
ORI = 0.19, P < 10
-5). Conversely, non-CGI proximal pro-
moters were strongly enriched for differential methyla-
tion (ORP = 3.10, ORI = 2.83, P < 10
-5). Also in
absolute terms, more tDMRs mapped to non-CGI
proximal promoters (nP = 781, nI = 1,100) than CGI
Figure 1 Example of the tDMR finder algorithm used for the HOXD3 gene. Tissue-specific differentially methylated regions were identified in
a two-step approach: first, we identified tDMPs. CpGs were considered to be tDMPs when there was a genome-wide significant mean
difference of ≥ 10%. The mean difference was expressed as a mean sum of squares. A difference ≥ 10% equals a mean sum of squares ≥ 0.01
(square of 10% = 0.12). To test whether the difference was significant, we applied a linear model per CpG site, with a random effect for each individual to
correct for any inter-individual variation. From this linear model we obtained a P value (F-test) per CpG site and used a multiple testing corrected P value
as a cut-off (10-7). Second, we identified tDMRs as regions with at least three tDMPs with an inter-CpG distance of at most 1 kb and a maximum of three
non-tDMPs. Mb, megabase; tDMP, tissue-specific differentially methylated position; tDMR, tissue-specific differentially methylated region.
Table 1 Characteristics of identified tDMRs
Number
of DMR
Number of
CpGs
Mean
length (SD)
Median
length (IQR)
Peripheral
tissues
3533 17067 605 (578) 442 (219–835)
Internal tissues 5382 27992 700 (646) 530 (259/942)
Unique between
datasets
4877 26285
Shared between
datasets
2019 9387
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proximal promoters (nP = 168, nI = 313; Additional file
10: Table S3 and Additional file 5: Table S2). In prox-
imal promoters, no enrichment of CGI shores was ob-
served (ORP = 0.82, ORI = 0.80), while CGI shelves
(that is, a 2 kb region flanking a CGI shore) showed a
similar enrichment compared to the non-CGI proximal
promoters (ORP = 3.10, ORI = 3.10, P < 10
-5). In ac-
cordance with the preferential occurrence of tDMRs at
non-CGI proximal promoters, the genes adjacent to
these tDMRs were strongly enriched for tissue-specific
gene expression, much more so than for CGI proximal
promoters (Figure 3).
Other regions showing evidence for enrichment for
tissue-specific methylation included CGIs in down-
stream regions (defined as the 3’ end to +5 kb relative to
the 3’ end; ORP = 1.46, P = 0.017; ORI = 1.76, P < 10
-5),
CGI shores in distal promoters (ORP = 1.59, ORI = 1.78,
P < 10-5) and CGI shores in downstream regions (ORP =
1.67, P = 4 × 10-4; ORI = 1.58, P = 1.2 × 10
-4). Of note,
no enrichment was observed for gene-body CGIs (de-
fined as +500 kb to the 3’ end relative to the gene). Of
the total number of tDMRs detected, ~25% overlapped
with a CGI shore and a similar percentage with a CGI
(Additional file 10: Table S3 and Additional file 5: Table S2).
The number of tDMRs overlapping with CGI shelves
was lower (~6%).
tDMRs are enriched in alternative transcription start sites
It has been suggested that DNA methylation regulates
alternative transcription [18], which may be the mechan-
ism underlying its contribution to tissue-specific expres-
sion. In support of this hypothesis, we observed
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Figure 2 Enrichment with tDMRs in the gene- and CpG-density centric annotation. Differences were observed between CGI and non-CGI
regions, especially in proximal promoters and downstream regions. Shores in distal promoters and downstream regions were enriched with tDMR
CpGs. Enrichment with tDMR CpGs in non-CGI features was limited to distal promoters and proximal promoters. * P < 10-5. CGI, CpG island; tDMR,
tissue-specific differentially methylated region.
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enrichment of tDMRs in alternative transcription start
sites (ORP = 2.34, ORI = 2.58, P < 10
-5; an example is
given in Additional file 11: Figure S6; see also Additional
file 5: Table S2). This was also reflected in the number
of tDMRs associated with alternative transcription start
sites (PT: 18.8%, IO: 20.9%). In addition, significant en-
richment was observed at mutually exclusive exons
(ORP = 1.47, ORI = 1.45, P < 10
-5) and cassette exons
(ORP = 1.37, ORI = 1.43, P < 10
-5) (Figure 4). Overall,
47.9% of tDMRs detected in the peripheral tissue dataset
and 49.8% of the tDMRs detected in the internal organ
dataset mapped to an alternative transcription event. It
was previously indicated that methylation of CGIs pri-
marily mediates the effects on alternative transcription
[10]. We could replicate the presence of a tDMR at a
CGI in the SHANK3 gene body, which was found to
regulate alternative transcription (Additional file 12:
Figure S7) [10]. However, only a minority of tDMRs
mapping to alternative transcription start sites (denoted
by the occurrence of alternative first exons) were CGIs
(PP = 14.5%; PI = 20.5%). The majority were non-CGI
sequences (PP = 52.5%; PI = 48.3%) indicating a role for
CpG-poor regions in the regulation of alternative
transcription.
Functional annotation of tDMRs
tDMRs were mapped to their nearest gene and enrich-
ment analysis of gene ontology (GO) terms was used to
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Figure 3 Enrichment of tDMR CpGs in genes that are preferentially expressed in studied tissues. Differential methylation of a non-CGI
proximal promoter was strongly associated with tissue-specific expression (TiGER database [17]) of the adjacent gene and much more so than for
differentially methylated CGI proximal promoters. tDMR CpGs were significantly enriched in all tissues in both proximal promoters with an island
and proximal promoters without a CpG island (P < 10-5). PT, peripheral tissue; tDMR, tissue-specific differentially methylated region.
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Figure 4 Enrichment of alternative event regions with tDMR CpGs. *P < 10-5. A3SS, alternative 3’ splice site; A5SS, alternative 5’ splice site;
ALE, alternative last exon; ATSS, alternative transcription start site; CE, cassette exon; CNE, constitutive exon; EI, exon isoforms; II, intron isoforms;
IR, intron retention; MXE, mutually exclusive exon; tDMR, tissue-specific differentially methylated region.
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describe functional categories. Non-CGI proximal pro-
moters harbouring a tDMR were found to be involved in
regulating tissue-specific processes reinforcing our previ-
ous observations of this class of tDMRs (Figure 5). In con-
trast, CGI proximal promoters harbouring a tDMR were
largely associated with embryonic development processes.
CGI shore proximal promoters with a tDMR were associ-
ated with similar processes as CGI proximal promoters
with a tDMR, whereas CGI-shelf proximal promoters with
a tDMR resembled non-CGI proximal promoters with a
tDMR. The functional annotations of other tDMRs classes
are given in Additional file 13: Figure S8.
tDMRs are enriched for regulatory regions
Regulatory DNA is marked by DNase I hypersensitive
sites (DHSs) [19]. DHSs were enriched for tDMRs
Figure 5 Enrichment of GO terms with nearest genes of tDMRs. Different colours represent the distinct major classes. Notice the difference in
major classes between genes enriched with tDMRs that have a CGI or CGI flanking region and those which do not. When no CGI is present, tissue-
specific genes are observed, while when there is a CGI present, the genes enriched with a tDMR are more often involved in embryonic developmental
processes and gene regulation genes. Genes with a differentially methylated shelf overlapping with the proximal promoter, were associated with
developmental -, housekeeping -, and tissue-specific GO terms. CGI, CpG island; GO, gene ontology; tDMR, tissue-specific differentially methylated
region.
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(ORP = 1.36, ORI = 1.37, P < 10
-5; Additional file 5: Table
S2 and Additional file 14: Figure S9). Using ENCODE data
on transcription factor binding sites (TFBSs) [20] we ob-
served enrichment for tissue-specific methylation at the
binding sites BCL11A (ORP = 3.22, ORI = 2.52, P < 10
-5),
SUZ12 (ORP = 1.71, ORI = 2.17, P < 10
-5) and FOXA2
(ORP = 1.12, P = 0.30; ORI = 1.61, P < 10
-5).
Hypomethylation at TFBSs was observed in tissues in
which the transcription factor is expressed (Additional file
15: Figure S10). For example, FOXA2 is active in the liver
[21], pancreas [22] and potentially hair follicles [23], and
FOXA2 binding sites were relatively hypomethylated in
these tissues. tDMRs, however, were depleted for many
other TFBSs, including for methylation-sensitive tran-
scription factors YY1 (ORP = 0.23, ORI = 0.25, P < 10
-5),
Egr-1 (ORP = 0.41, ORI = 0.41, P < 10
-5) and NFkB (ORP =
0.44, ORI = 0.41, P < 10
-5).
Correlation of inter-individual variation across tissues
We investigated the occurrence of inter-individual vari-
ation in the internal tissue dataset after exclusion of
CpG sites overlapping with known SNPs. Although
tissue-differences were the main driver of variation in
DNA methylation, we observed inter-individual variation
for 15,803, 11,719, 46,437 and 8,415 CpGs in the liver,
subcutaneous fat, omentum and skeletal muscle, respect-
ively (defined as a mean sum of squares > 0.025). The
large number of variable CpGs observed in omentum
may reflect the cellular heterogeneity of this tissue. For
the variable CpG sites identified, we calculated the cor-
relation between the between-individual difference for
the internal tissue and the between-individual difference
for blood (Figure 6A). When restricting these CpG sites
to those with a correlation >0.8, the within-individual
DNA methylation in blood correlated to variable DNA
methylation in the liver, subcutaneous fat, omentum and
skeletal muscle for 5,532, 3,909, 10,905 and 2,446 CpGs,
respectively. Many of the correlated CpG sites were
unique for a single internal tissue and blood but others
were correlated across multiple tissues (Figure 6B).
While the former may represent a genuine epigenetic
correlation, in particular CpGs correlating across all tis-
sues may frequently be driven by genetic variation influ-
encing local DNA methylation (Figure 6C).
Discussion
In this study we report on genome-wide methylation
patterns generated using multiple peripheral and internal
tissues from two independent sets of donors using 450k
methylation chips. Although the 450k platform interro-
gates a small subset of the ~28M CpG sites in the hu-
man genome, it relatively comprehensively evaluates
promoter regions and CpG islands, and also covers other
potentially relevant features, including downstream
genic and intergenic regions. A new algorithm was able
to identify statistically robust tDMRs as illustrated by a
statistically significant overlap in the location of tDMRs
between the datasets. The biological relevance of the
identified tDMRs was highlighted by the observation
that they mapped to genes with tissue-specific expres-
sion and also showed hypomethylation specifically in the
tissue expressing those genes. Annotation of tDMRs
showed that they can occur irrespective of their position
relative to genes or local CpG density. Tissue-specific
DNA methylation was most evident, however, both ab-
solutely and relatively, in regions outside CGIs or CGI
flanking regions. This confirms previous studies
reporting a high prevalence of CpG-poor regions near
genes with tissue-specific expression both in humans
[2,3,7] and animals [24,25].
One of our key findings is that the role of non-CGI
tDMRs may frequently involve the regulation of alterna-
tive transcription. Tissue-specific methylation was asso-
ciated with alternative transcription start sites and,
B CA
Figure 6 Within-individual correlation in DNA methylation between tissues. (A) Relation between differences within two individuals in
blood versus one other tissue. (B) Venn diagram of the number of CpGs sites that are correlated between blood and one or more tissues.
(C) Top: A variably methylated CpG site in muscle that is correlated with DNA methylation in blood. Bottom: A variably methylated CpG site that
is correlated across all tissues likely due to the influence of SNPs. SC, subcutaneous; SNP, single nucleotide polymorphism.
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despite being sparsely covered by the 450k chip, mutu-
ally exclusive exons and cassette exons. A previous study
adopting a descriptive approach combined with func-
tional validation suggested a primary role for DNA
methylation at CGIs in alternative transcription [10]. Al-
though we could confirm tissue-specific methylation at
CGIs with a validated effect on alternative transcription
from that study, our statistical approach highlighted the
role of non-CGI regions in alternative transcription start
sites. Interestingly, a recent study also supported a role
for DNA methylation in controlling mutually exclusive
exons underlining the validity of our results [26]. The
link between DNA methylation, non-CGI sequences and
alternative transcription arising from our data is in line
with their hypothesized role in vertebrate evolution [27].
Recent studies of differential methylation between tis-
sues emphasized the occurrence of tDMRs outside non-
CGI and CGI proximal promoters. For example, studies
of animal models [5,9] and subsequently humans
underscored the occurrence of tDMRs in gene-body
CGIs [11]. Although the 450k chip comprehensively as-
sesses methylation at CGIs, only ~4% of the tDMRs
detected in our study mapped to a gene-body CGI. An-
other feature that attracted significant attention is CGI
shores, which are the 2 kb regions flanking CGIs.
Irizarry et al. reported that 76% of the tDMRs identified
overlapped with CGI shores [12]. Inspired by this work,
the 450k chip was designed with the specific aim of cov-
ering CGI shores. Nevertheless, the percentage of CGI-
shore tDMRs in our data was limited to ~25% of the
total number of tDMRs. However, our data indicated
that tissue-specific methylation at CGIs and CGI shores
may be more relevant at downstream genic regions,
which remain poorly studied. Of note, we found that dif-
ferentially methylated CGI shores were associated with
genes involved in housekeeping and developmental
processes analogous to differentially methylated CGIs.
tDMRs overlapping with so called CGI shelves (the re-
gions flanking CGI shores) mapped to genes associated
with tissue-specific processes, as was observed for non-
CGI tDMRs. Our results indicate that the occurrence of
tDMRs may be less biased towards previously suggested
annotations including gene-body CGIs and CGI shores,
and reinforce the potential utility of reconsidering
current definitions of CGI annotations [12,28-30].
The annotation of tDMRs has thus far primarily fo-
cussed on CG content and location relative to genes. In-
creasing knowledge of genome biology can give a more
in-depth annotation. The ENCODE project mapped
DNase I hypersensitive sites (DHSs), informative markers
of regulatory DNA and transcription factor binding sites
(TFBSs) across 349 cell lines [19]. Both DHSs and
TFBSs were enriched for tDMRs in our study. TFBS en-
richment was observed for transcription factors (TFs)
with a tissue-specific function and the TFBSs for these
TFs were hypomethylated at TFBSs in the tissue in
which they are expressed. These results are in accord-
ance with the hypothesis that TF binding is associated
with hypomethylation of TFBSs [31,32].
Although the largest variation in DNA methylation
was observed between tissues, it is more relevant to in-
vestigate inter-individual variation from the perspective
of epigenetic epidemiology, which aims at identifying
epigenetic risk factors for disease. Epidemiological stud-
ies, however, often have to rely on accessible peripheral
tissues as proxies for internal organs directly involved in
the aetiology of the disease of interest [33]. Our explor-
ation of the concordance between blood and internal
tissues at CpG sites with variable DNA methylation sug-
gested the presence of good correlations for a subset of
variable CpG sites, many of which were locus and
tissue-specific. Variable CpGs correlating across blood
and all internal tissues may be primarily mediated by the
effects of SNPs on DNA methylation [34] and may not
necessarily represent a genuine epigenetic correlation.
The initial evidence that blood DNA methylation may
correlate to that of internal tissues as presented here and
brain regions as reported previously [11] warrants inves-
tigations of more individuals and more tissues, such as
the GTEx project [35], to work towards an atlas cata-
loguing those variably methylated regions in internal tis-
sues that could potentially be studied indirectly by
assessing their DNA methylation in specific peripheral
tissues.
Conclusions
In conclusion, using an effective approach to detect and
annotate tDMRs in 450k methylation data, we highlight
the importance of non-CGI regions in tissue-specific
DNA methylation and provide further evidence for a
role of differential DNA methylation in the regulation of
alternative transcription. Moreover, our data suggest that
peripheral tissues may to some extent be used to assess
inter-individual differences in DNA methylation in in-
ternal organs that frequently remain inaccessible in epi-
demiological studies.
Methods
DNA isolation and Illumina 450k BeadChip
For the peripheral tissue dataset, five healthy volunteers
from laboratory personnel (mean age 28 years, SD = 6.1)
donated blood, saliva, hair and buccal swabs after pro-
viding informed consent. DNA was isolated from the
blood using the Qiagen mini kit (Qiagen, Germany)
using the manufacturer’s protocol. DNA from hair folli-
cles was also isolated using Qiagen mini kits, with the
addition of 3 μL dithiothreitol (DTT) during lysis to en-
hance the lysis of the hair follicles. DNA was isolated
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from saliva using Oragene Discover kits (OGR-250,
DNA Genotek Inc). DNA from buccal swabs was iso-
lated using a chloroform/isoamyl alcohol protocol [36].
For the internal tissue dataset, samples were taken from
six cadavers within 12 h post-mortem (mean age 65.5
years, SD = 7.2; Additional file 1: Table S1). Blood was
collected from the thoracic cavity in ethylenediamine-
tetraacetic acid disodium salt dihydrate (EDTA) tubes
(BD, United Kingdom). Tissue samples were collected
and snap frozen onto a cork template with Tissue-Tek
(Tissue-Tek, Netherlands). Samples were stored at −80°C
until DNA extraction. To enhance lysis, tissues were sliced
into 30-μm slices using a cryostat (Leica, Germany). For
microscopic inspection, one 5-μm slice was stained
with haematoxylin and eosin (HE). HE tissue slides
were microscopically inspected to verify tissue integrity and
homogeneity and to exclude inflammatory infiltrate. DNA
was extracted using a chloroform/isoamyl alcohol protocol.
DNA concentrations were determined using a PicoGreen
dsDNA quantitation assay (Invitrogen). Bisulphite reac-
tions were performed using the EZ-96 DNA methyla-
tion kit (Zymo Research, Orange County, USA) with
an input of 1 μg of genomic DNA. After bisulphite
conversion, each sample was whole-genome amplified,
enzymatically fragmented, and hybridized to the Illumina
HumanMethylation450 BeadChip.
Ethics statement
This study was conducted according to the principles
expressed in the Declaration of Helsinki. All samples
were anonymized and procedures were performed
according to the ethical guidelines in the Code for Proper
Secondary Use of Human Tissue in The Netherlands
(Dutch Federation of Medical Scientific Societies).
(Pre-)processing of the Illumina 450k BeadChip data
All analyses were performed in using R statistics, version
2.15.1. SNPs on the array were used to confirm that tis-
sue samples were from the same individual and CpGs on
the X and Y chromosome were used to confirm gender.
CpGs with a detection P value (a value representing the
measured signal compared to negative controls) over
0.05 were removed from the data. Cluster analysis (based
on Euclidian distance) did not reveal signs of batch ef-
fects. The distributions of the six different signals on
the 450k array (Type I (red/green and methylated/
unmethylated) and Type II (red/green)) were quantile
normalized separately. Quality control plots were
obtained using functions from the R package minfi and
custom scripts [37].
tDMR identification
Using the R package IlluminaHumanMethylation450k.
db, Illumina identifiers were mapped to the hg19
genome build [38]. In order to objectively identify tDMRs
we applied a newly developed algorithm (Figure 1). First
differentially methylated positions were identified. The al-
gorithm identifies tDMRs in two steps. CpGs were consid-
ered a tDMP on the basis of statistical significance and
effect size. First we applied two linear models per CpG
site, one with a fixed effect for tissue and one without
(Figure 1):
yj ¼ β0þ β1 ⋅T þ b1 ⋅ I þ ε ð1Þ
yj ¼ β0 þ b1 ⋅ I þ ε ð2Þ
where yj is the methylation value for CpG j, β1 the fixed
effect for tissues and b1 is a random effect term for the in-
dividual. We tested whether the model with the fixed ef-
fect for tissue fitted the data better with the F test and
used a Bonferroni corrected P value ≤ 10-7 (0.05/471k
autosomal CpGs) as the threshold for statistical signifi-
cance after correction for multiple testing. Statistical ana-
lysis was performed using the R package lme4 [39]. Since
individual CpG sites were evaluated, the statistical test
was not influenced by the systematic difference between
type 1 and type 2 probes on the 450k chip. Second, we cal-
culated the measure for effect size and we used the mean
sum of squares (analogous to the effect size parameter
evaluated in the F test), which was calculated as:
X
yi;j−yj
 2
n
ð3Þ
where yi;j is the mean methylation of tissue i of CpG j, yi
is the overall mean methylation of CpG j and n the num-
ber of tissues studied. The cut-off we used for the effect
size was a 20% difference in DNA methylation between
two tissues, which equals a ≥10% difference from the over-
all mean (≥10% difference equals a mean sum of
squares ≥0.01 since the square of 10% = 0.12). Using
both an effect size and the P value cut-off, CpG sites
were classified as tDMP or non-tDMP. In the second
stage of the algorithm, we used the DMP status to iden-
tify DMRs, which were defined as ≥3 DMPs with an
inter-CpG distance of ≤ 1 kb while allowing ≤ 3 non-
DMPs in the complete DMR. This procedure assumes
that the DNA methylation level of CpGs not measured
using the 450k chip, but located in a tDMR called by the
algorithm, are similar to the CpGs that were measured
and led to the calling of a tDMR. This assumption is based
on previous studies that reported high levels of co-
methylation at shorter genomic distances (<1 kb) particu-
larly in non-repeat regions (as interrogated using the 450k
chip), for example, in candidate loci [13], in 27k data [34]
and in whole genome bis-seq data [40]. The presence of
co-methylation was confirmed in the current dataset
(Additional file 3: Figure S2B). Different settings for the
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inter-CpG distance (1.5 kb and 2 kb instead of 1 kb) or
mismatches (1, 2, 4 and 5 instead of 3) did not appreciably
alter the number and length of detected tDMRs, indicat-
ing the stability of the algorithm. The DMR finder algo-
rithm was implemented in R statistics and the script is
available in Additional file 4. The DMR finder can be used
for 450k data (using Illumina CpG identifiers) as well for
other types of DNA methylation data (using genomic
locations).
Annotation and enrichment tests
CpGs on the 450k chip were annotated in multiple ways.
First, the genome was divided according to five gene-
centric regions: the inter-genic region (>10 kb from the
nearest TSS), the distal promoter (−10 kb to 1.5 kb from
the nearest TSS), the proximal promoter (−1.5 kb to +500
bp from the nearest TSS), the gene body (+500 bp to 3’
end of the gene) and the downstream region (3’ end to +5
kb from 3’ end). Next, CpGs were annotated as non-CGI,
CGI, CGI shore or CGI shelf. Genomic locations of CpG
islands were obtained from the UCSC browser [41]. CGI
shores were defined as 2 kb flanking the CpG island up-
and downstream and CGI shelves as 2 kb flanking the
CGI shore. Genes displaying tissue-specific expression
were obtained from the TiGER database [17]. Alternative
transcription/splicing events were downloaded from
Ensembl [42-44]. The DNase hypersensitive sites and
transcription factor binding sites clustered for multiple
cell lines as part of the ENCODE project [20] were
downloaded from the UCSC browser. All annotations
used in this paper are available from Additional file 8,
Additional file 16, Additional file 17 and Additional file 18
as RData objects; these include annotations of genomic
features, alternative events, DHSs and transcription factor
binding sites. All annotations are based on human genome
build 19.
Enrichments, that is, the gene and CpG density centric
enrichments, tissue-specific expressed genes, the alterna-
tive events, the transcription factor binding sites and the
DHSs were calculated using the individual CpG sites
within tDMRs. All odds ratios were corrected for back-
ground enrichment, which is required because not all
CpG sites on the array can become a tDMR as a result
of the varying density of the chips. The background odds
ratio was determined by identifying tDMR-like regions,
that is, regions with an inter-CpG distance smaller than
1 kb with an average length of 5 CpGs per tDMR-like re-
gions (cf. the number of CpGs in identified tDMRs)
resulting in ~8 × 104 tDMR-like regions. Reported odds
ratios are the calculated odds ratio divided by the back-
ground odds ratio. For each enrichment test, we
performed 200,001 permutations with 4,500 tDMR-like
regions each. Using the resulting empirical distribution,
we determined the two-sided P value for enrichment.
Gene ontology term analysis
tDMRs overlapping with an annotation were mapped to
the nearest gene using GREAT [45]. Extracted genes were
tested for enrichment of GO terms using the GO_BP_FAT
table from the DAVID tool [46,47]. To gain further in-
sights regarding the major classes within the significant
GO terms, the REVIGO tool was used to cluster and
prune GO terms on the basis of P values obtained from
DAVID, with a medium allowed similarity [48]. Gene re-
gion figures were generated using the R package Gviz [49]
and graphs with the R package ggplot2 [50].
Individual variation
To determine individual variation we used liver, subcuta-
neous fat, omentum and muscle from six autopsy subjects
from which we obtained all these tissues. CpGs were
mapped to the nearest flanking SNP using the Phase I/II
CEU SNPs from the 1000 Genomes project. All SNPs
in the probe and CpG SNPs were removed from the
data (n = 147,963). To determine inter-individual vari-
ation we calculated the mean sum of squares for all
CpG sites and selected the CpGs with a mean sum of
squares >0.025. Correlations between blood and in-
ternal tissues were calculated by determining the cor-
relation between all inter-individual comparisons in
blood, compared to all inter-individual comparisons in
one internal tissue and CpGs with a correlation over
0.8 were selected.
Data access
The data used in this publication have been deposited in
NCBI’s Gene Expression Omnibus [51] and are access-
ible through GEO Series accession number GSE48472.
Additional files
Additional file 1: Table S1. Characteristics of subjects and tissues. IT,
internal tissue; PT, peripheral tissue.
Additional file 2: Figure S1. Quality control figures for both datasets.
(A, B) Densities of the quantile normalized beta values. A characteristic
bimodal distribution is present as expected. (C, D) The median log2
intensities are high, suggesting the arrays have a decent quality. (E, F)
Tissues cluster according to tissue type. SC, subcutaneous.
Additional file 3: Figure S2. General characteristics of the data. (A)
DNA methylation around the TSS demonstrates a previously observed
canonical pattern. (B) Inter-CpG distance versus the absolute difference in
beta. Notice that when the inter-CpG distance rises, the difference in DNA
methylation also increases with a plateau at 1 kb. (C) Circos representation
of the location of the tDMR CpGs in the genome. The three circles from
outer to inner are for the internal tissues dataset, the peripheral tissues
dataset and the common CpGs between the two, respectively. kb, kilobase;
tDMR, tissue-specific differentially methylated region.
Additional file 4: The newly developed DMR finder. Zip file with the
R scripts used to identify DMRs. The Start file DMRfinder.R script contains
the front end for users and the DMRfinder.R the backbone of the
algorithm. The algorithm can detect DMRs in 450k data (Illumina IDs/
genomic locations) and other types of data (genomic locations). DMR,
differentially methylated region.
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Additional file 5: Table S2. Identified DMRs with associated
annotations and intra-individual correlated CpG sites. DMR, differentially
methylated region; IT, internal tissue; PT, peripheral tissue.
Additional file 6: Figure S3. Heat map of DNA methylation of tDMR
CpGs in both datasets. (A) Peripheral tissues. (B) Internal tissues. tDMR,
tissue-specific differentially methylated region.
Additional file 7: Figure S4. Enrichment and DNA methylation of
tDMR CpGs in genes that are expressed in specific tissues. (A) Enrichment
of tDMR CpGs in genes that are preferentially expressed in a particular
tissue (x axis). (B) DNA methylation in the tissues studied of the CpGs that
are associated with a gene preferentially expressed in a specific tissue.
Notice a drop in methylation in tissue in which it is expressed, while
higher methylation is observed in the other tissues. BL, blood; BU, buccal;
HA, hair; IT, internal tissue; LI, liver; MU, muscle; OM, omentum; PA,
pancreas; PT, peripheral tissue; SA, saliva; SF, subcutaneous fat; SP, spleen;
tDMR, tissue-specific differentially methylated region.
Additional file 8: Gene and CpG density centric annotation. This
RData object can be opened with R statistics. It contains a CGI and
gene-centric annotation of Illumina 450k CpG sites. CGI, CpG island.
Additional file 9: Figure S5. Enrichment of tDMR CpGs in the
gene-centric annotation. Blue and pink bars represent enrichment with
tDMRs of genomic features in peripheral tissues and internal tissues,
respectively, relative to background enrichments. tDMRs are enriched in
all genomic features, while depleted in proximal promoters. tDMR,
tissue-specific differentially methylated region.
Additional file 10: Table S3. Genomic location of tDMRs in both
datasets. CGI, CpG island; tDMR, tissue-specific differentially methylated
region.
Additional file 11: Figure S6. Example of alternative promoter usage.
There are more transcription start sites for the DDR1 gene and differential
methylation was observed in all proximal promoters of all transcripts.
DMR, differentially methylated region; Mb, megabase; SC, subcutaneous;
tDMR, tissue-specific differentially methylated region.
Additional file 12: Figure S7. DNA methylation of the SHANK3 gene. A
tDMR at a CGI in the SHANK3 gene body has been reported to regulate
alternative transcription [10] and in line with this report we observed
differential methylation at the CGIs. CGI, CpG island; Mb, megabase; SC,
subcutaneous; tDMR, tissue-specific differentially methylated region.
Additional file 13: Figure S8. Enrichment of differentially methylated
genes in GO terms. Colours represent major classes of types of GO terms
found to be enriched. Notice that tissue-specific genes are mainly
enriched in non-CGI features, but also in proximal promoter shelves. CGI,
CpG island; GO, gene ontology.
Additional file 14: Figure S9. GO term analysis of genes mapping to
tDMRs in DHSs, DHS, DNase I hypersensitive site; GO, gene ontology;
tDMR, tissue-specific differentially methylated region.
Additional file 15: Figure S10. DNA methylation of tDMR CpGs maps
to the transcription factor binding sites (above plots). The upper row is
the peripheral tissue dataset; bottom row the internal tissue dataset. BL,
blood; BU, buccal; HA, hair; LI, liver; MU, muscle; OM, omentum; PA,
pancreas; PT, peripheral tissue; SA, saliva; SF, subcutaneous fat; SP, spleen;
tDMR, tissue-specific differentially methylated region.
Additional file 16: Annotation of alternative events. This RData
object can be opened with R statistics. It contains an annotation of
Illumina 450k CpG sites for Ensembl alternative transcription events.
Additional file 17: Annotation of transcription factor binding sites.
This RData object can be opened with R statistics. It contains an
annotation of Illumina 450k CpG sites to ENCODE transcription factor
binding sites.
Additional file 18: Annotation of transcription factor binding sites.
This RData object can be opened with R statistics. It contains an annotation
of Illumina 450k CpG sites to ENCODE DNA hypersensitive sites.
Abbreviations
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